Engagement Agreement TRANSGENOMIC Inc. (together with its subsidiaries and affiliates the “COMPANY”)Engagement Agreement • November 23rd, 2004 • Transgenomic Inc • Laboratory analytical instruments • Delaware
The parties to this Engagement Agreement (the “Agreement”) include Goldsmith, Agio, Helms Securities, Inc. (“GAHS”) on the one hand, and the COMPANY on the other hand. This is to confirm the COMPANY’s retention of GAHS for a minimum period of four (4) months from the date hereof (the “Minimum Term”), as its exclusive financial advisor to assist it with a merger, sale, or any similar transaction related to the COMPANY’s Synthetic Nucleic Acid Business Unit, (including both the Boulder, Colorado site and the Glasgow, Scotland site) (the “SNABU”). After four (4) months, GAHS will proceed on such basis as is reasonably agreed upon between the parties or on a holdover basis until either GAHS or the COMPANY provides the other with written 30-day notice of termination of this Agreement.
